Intensive Lifestyle Interventions Cut Long-Term Disability in T2DM

Share this content:
Intensive Lifestyle Interventions Cut Long-Term Disability in T2DM
Intensive Lifestyle Interventions Cut Long-Term Disability in T2DM

MONDAY, March 26, 2018 (HealthDay News) -- For overweight or obese adults with type 2 diabetes, a long-term weight loss intervention is associated with a reduction in long-term disability, according to a study published online March 15 in Diabetes Care.

Edward W. Gregg, Ph.D., from the U.S. Centers for Disease Control and Prevention in Atlanta, and colleagues randomized 5,145 overweight or obese adults with type 2 diabetes aged 45 to 76 years to a 10-year intensive lifestyle intervention (ILI) or diabetes support and education (DSE). The Short Form-36 was used to assess physical function annually for 12 years.

The researchers found that the incidence of physical disability was lower in the ILI versus the DSE group (6.0 versus 6.8 percent per year; incidence rate ratio, 0.88), whereas there was no difference in the rates of disability remission and mortality. Compared with DSE participants, ILI participants had a significant delay in moderate or severe disability onset, and an increase in the number of nondisabled years. This effect translated into 0.9 more disability-free years for a 60-year-old (12.0 versus 11.1 years); there was no difference in total years of life. ILI increased disability-free years of life in women and those without cardiovascular disease (CVD), but not in men or those with CVD, in stratified analyses.

"Long-term lifestyle interventions among overweight or obese adults with type 2 diabetes may reduce long-term disability, leading to an effect on disability-free life expectancy but not on total life expectancy," the authors write.

Abstract/Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters


More in Home

Low-Dose Hyaluronidase Can Remove Hyaluronic Acid Fillers

Low-Dose Hyaluronidase Can Remove Hyaluronic Acid Fillers

Greater resolution of nodules with hyaluronidase versus saline; more rapid resolution with higher doses

Improvement in Race-Based Disparities in Years of Life Lost

Improvement in Race-Based Disparities in Years of Life ...

Decline in race-based disparities in years of life lost seen in the United States from 1990 to 2014

Drug-Related Endocarditis Cases Up From 2007 to 2015

Drug-Related Endocarditis Cases Up From 2007 to 2015

Increase in endocarditis over nine-year study period mirrored increase in concomitant mixed drug use

is free, fast, and customized just for you!

Already a member?

Sign In Now »